Fronto Temporal Dementia clinical trials

Explore recruiting fronto temporal dementia clinical trials.

Recruiting fronto temporal dementia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Fronto Temporal Dementia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Ascending Dose Study to Evaluate the Safety and Effects on Progranulin Levels of LY3884963 in Patients with Fronto-Temporal Dementia with Progranulin Mutations (FTD-GRN) (PROCLAIM)

France, Belgium

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Fronto Temporal Dementia trials by city

Fronto Temporal Dementia in Toronto Fronto Temporal Dementia in Vancouver Fronto Temporal Dementia in Montreal Fronto Temporal Dementia in Calgary Fronto Temporal Dementia in Edmonton Fronto Temporal Dementia in Ottawa Fronto Temporal Dementia in Winnipeg Fronto Temporal Dementia in Quebec City Fronto Temporal Dementia in Hamilton Fronto Temporal Dementia in Kitchener Fronto Temporal Dementia in London Fronto Temporal Dementia in Halifax Fronto Temporal Dementia in New York Fronto Temporal Dementia in Los Angeles Fronto Temporal Dementia in Chicago Fronto Temporal Dementia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease